Key facts
- ALKEON CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for Oric Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (ORIC).
- Disclosed ownership: 4.6%.
- Date of event: 30 Sep 2025.
ALKEON CAPITAL MANAGEMENT LLC - 30 Sep 2025 SCHEDULE 13G/A Report for Oric Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (ORIC)
- Filing Manager
- ALKEON CAPITAL MANAGEMENT LLC
- Reporting Manager
- Alkeon Capital Management LLC
- Symbol
- ORIC
- Shares outstanding
- 97,915,130 shares
- Disclosed Ownership
- 4,504,096 shares
- Ownership
- 4.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Nov 2025, 18:15:36 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Key filing fact
ALKEON CAPITAL MANAGEMENT LLC disclosed 4.6% ownership in Oric Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (ORIC) on 30 Sep 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Nov 2025, 18:15.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Alkeon Capital Management LLC | 4.6% | 4,504,096 | 0 | 4,504,096 | /s/ Jennifer Shufro | Jennifer Shufro, Compliance Officer | |
| Panayotis D. Sparaggis | 4.6% | 4,504,096 | 0 | 4,504,096 | /s/ Panayotis D. Sparaggis | Panayotis D. Sparaggis, individually |
CIK / CUSIP context first